RELMADA THERAPEUTICS, INC.: stockholders equity

What this measure means

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-08-31 to 2025-12-31. The SEC response was captured on 2026-09-19.

Selected filing history

Related financial histories

• RELMADA THERAPEUTICS, INC.: total assets
• RELMADA THERAPEUTICS, INC.: total liabilities
• RELMADA THERAPEUTICS, INC.: cash and cash equivalents
• RELMADA THERAPEUTICS, INC.: net income or loss
• RELMADA THERAPEUTICS, INC.: operating cash flow
• RELMADA THERAPEUTICS, INC.: financing cash flow
• RELMADA THERAPEUTICS, INC.: investing cash flow
• RELMADA THERAPEUTICS, INC.: retained earnings or deficit
• RELMADA THERAPEUTICS, INC.: basic weighted-average shares
• RELMADA THERAPEUTICS, INC.: diluted weighted-average shares
• RELMADA THERAPEUTICS, INC.: basic earnings per share
• RELMADA THERAPEUTICS, INC.: diluted earnings per share
• RELMADA THERAPEUTICS, INC.: net property, plant and equipment
• RELMADA THERAPEUTICS, INC.: share-based compensation expense
• RELMADA THERAPEUTICS, INC.: operating income or loss
• RELMADA THERAPEUTICS, INC.: current assets
• RELMADA THERAPEUTICS, INC.: current liabilities
• RELMADA THERAPEUTICS, INC.: current accounts payable
• RELMADA THERAPEUTICS, INC.: operating expenses
• RELMADA THERAPEUTICS, INC.: research and development expense

Inspect the source

Entity

RELMADA THERAPEUTICS, INC. / CIK 0001553643

Captured

2026-09-19T11:18:56.464Z

SEC response SHA-256

34acb6579adb694402af1f940d83014f7841c8cf763b03e27ee64d386466bb53

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001553643.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))